p70 Ribosomal S6 kinase is required for airway smooth muscle cell size enlargement but not increased contractile protein expression.
暂无分享,去创建一个
D. Fingar | K. Bitar | J. Solway | J. Lei | M. Hershenson | H. Deng | J. Bentley | Jing Lei
[1] W. Henderson,et al. Airway smooth muscle hyperplasia and hypertrophy correlate with glycogen synthase kinase-3(beta) phosphorylation in a mouse model of asthma. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[2] D. Fingar,et al. Inhibition of Glycogen Synthase Kinase-3β Is Sufficient for Airway Smooth Muscle Hypertrophy* , 2008, Journal of Biological Chemistry.
[3] D. Fingar,et al. Transforming growth factor-β induces airway smooth muscle hypertrophy , 2006 .
[4] Steven P. Gygi,et al. mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.
[5] D. Fingar,et al. 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. , 2005, American journal of respiratory cell and molecular biology.
[6] T. Bai,et al. Cardiotrophin-1 alters airway smooth muscle structure and mechanical properties in airway explants. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[7] J. Blenis,et al. Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy , 2004, Molecular and Cellular Biology.
[8] P. Woodruff,et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. , 2004, American journal of respiratory and critical care medicine.
[9] E. Raz,et al. Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling. , 2004, American journal of respiratory cell and molecular biology.
[10] J. McConville,et al. K Regulates Contractile Protein Accumulation in Airway Myocyte Differentiation , 2004 .
[11] A. Halayko,et al. Expression and effects of cardiotrophin‐1 (CT‐1) in human airway smooth muscle cells , 2003, British journal of pharmacology.
[12] J. Kamei,et al. Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells. , 2003, European journal of pharmacology.
[13] M. Aubier,et al. Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.
[14] M. Laviolette,et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[15] P. O'Byrne,et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. , 2002, American journal of respiratory cell and molecular biology.
[16] J. Blenis,et al. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.
[17] K. Sekizawa,et al. Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor‐bβ , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] C. Rommel,et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.
[19] C. Proud,et al. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.
[20] M. Mann,et al. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] W. J. Wu,et al. Cdc42 Stimulates RNA Splicing via the S6 Kinase and a Novel S6 Kinase Target, the Nuclear Cap-binding Complex* , 2000, The Journal of Biological Chemistry.
[22] E. Hafen,et al. Drosophila S6 kinase: a regulator of cell size. , 1999, Science.
[23] F. Saulnier,et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. , 1999, American journal of respiratory and critical care medicine.
[24] M. Palacín,et al. p70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells. , 1998, Endocrinology.
[25] Stefano Fumagalli,et al. Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.
[26] R. Martin,et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.
[27] M. Jordana,et al. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. , 1996, American journal of respiratory cell and molecular biology.
[28] P. Howarth,et al. Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. , 1995, American Journal of Respiratory and Critical Care Medicine.
[29] P. Sassone-Corsi,et al. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression , 1994, Cell.
[30] M. Ebina,et al. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. , 1993, The American review of respiratory disease.
[31] H. Counihan,et al. Eridothelin immunoreactivity of airway epithelium in asthmatic patients , 1991, The Lancet.
[32] A. Halayko,et al. Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[33] D. Fingar,et al. Transforming growth factor-beta induces airway smooth muscle hypertrophy. , 2006, American journal of respiratory cell and molecular biology.